Wednesday, July 30, 2014 6:46:41 PM
The article I linked is authored by a man that has a hypothesis that MST 188 May be a potential treatment option for this disease. It is just that, his hypothesis and it appears that he reached out to Mast and they found his article of interest. That's really it right now. I thought the article made sense when I found it and since it mentioned our lead drug candidate I linked it here.
The author seems to be very passionate about finding treatment options for this rare disease. This is not a Seeking Alpha type of article meant to sway investors one way or another. It is an article he wrote for a Scleroderma focused website as information for those associated in some way with this disease, and I stumbled upon it on a weekend evening surfing the net.
That's about all I have for you on this. I hope that helps.
RR
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM